Annette R Kaufman1, Lila J Finney Rutten2, Mark Parascandola3, Kelly D Blake4, Erik M Augustson3. 1. Tobacco Control Research Branch. Electronic address: kaufmana@mail.nih.gov. 2. Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, Minnesota. 3. Tobacco Control Research Branch. 4. Health Communication and Informatics Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
Abstract
BACKGROUND: The Family Smoking Prevention and Tobacco Control Act granted the Food and Drug Administration (FDA) the authority to regulate tobacco products in the U.S. However, little is known about how regulation may be related to judgments about tobacco product-related risks. PURPOSE: To understand how FDA tobacco regulation beliefs are associated with judgments about tobacco product-related risks. METHODS: The Health Information National Trends Survey is a national survey of the U.S. adult population. Data used in this analysis were collected from October 2012 through January 2013 (N=3,630) by mailed questionnaire and analyzed in 2013. Weighted bivariate chi-square analyses were used to assess associations among FDA regulation belief, tobacco harm judgments, sociodemographics, and smoking status. A weighted multinomial logistic regression was conducted where FDA regulation belief was regressed on tobacco product judgments, controlling for sociodemographic variables and smoking status. RESULTS: About 41% believed that the FDA regulates tobacco products in the U.S., 23.6% reported the FDA does not, and 35.3% did not know. Chi-square analyses showed that smoking status was significantly related to harm judgments about electronic cigarettes (p<0.0001). The multinomial logistic regression revealed that uncertainty about FDA regulation was associated with tobacco product harm judgment uncertainty. CONCLUSIONS: Tobacco product harm perceptions are associated with beliefs about tobacco product regulation by the FDA. These findings suggest the need for increased public awareness and understanding of the role of tobacco product regulation in protecting public health.
BACKGROUND: The Family Smoking Prevention and Tobacco Control Act granted the Food and Drug Administration (FDA) the authority to regulate tobacco products in the U.S. However, little is known about how regulation may be related to judgments about tobacco product-related risks. PURPOSE: To understand how FDA tobacco regulation beliefs are associated with judgments about tobacco product-related risks. METHODS: The Health Information National Trends Survey is a national survey of the U.S. adult population. Data used in this analysis were collected from October 2012 through January 2013 (N=3,630) by mailed questionnaire and analyzed in 2013. Weighted bivariate chi-square analyses were used to assess associations among FDA regulation belief, tobacco harm judgments, sociodemographics, and smoking status. A weighted multinomial logistic regression was conducted where FDA regulation belief was regressed on tobacco product judgments, controlling for sociodemographic variables and smoking status. RESULTS: About 41% believed that the FDA regulates tobacco products in the U.S., 23.6% reported the FDA does not, and 35.3% did not know. Chi-square analyses showed that smoking status was significantly related to harm judgments about electronic cigarettes (p<0.0001). The multinomial logistic regression revealed that uncertainty about FDA regulation was associated with tobacco product harm judgment uncertainty. CONCLUSIONS:Tobacco product harm perceptions are associated with beliefs about tobacco product regulation by the FDA. These findings suggest the need for increased public awareness and understanding of the role of tobacco product regulation in protecting public health.
Authors: Richard J O'Connor; Andrew Hyland; Gary A Giovino; Geoffrey T Fong; K Michael Cummings Journal: Am J Prev Med Date: 2005-08 Impact factor: 5.043
Authors: David E Nelson; Gary L Kreps; Bradford W Hesse; Robert T Croyle; Gordon Willis; Neeraj K Arora; Barbara K Rimer; K V Viswanath; Neil Weinstein; Sara Alden Journal: J Health Commun Date: 2004 Sep-Oct
Authors: Geoffrey T Fong; Tara Elton-Marshall; Pete Driezen; Annette R Kaufman; K Michael Cummings; Kelvin Choi; Jonathan Kwan; Amber Koblitz; Andrew Hyland; Maansi Bansal-Travers; Charles Carusi; Mary E Thompson Journal: Addict Behav Date: 2018-11-17 Impact factor: 3.913
Authors: Allison M Schmidt; Kristen L Jarman; Leah M Ranney; Tara L Queen; Seth M Noar; Laura Ruel; Robert Agans; Anika Hannan; Adam O Goldstein Journal: Nicotine Tob Res Date: 2018-09-25 Impact factor: 4.244
Authors: Mia Jovanova; Chris Skurka; Sahara Byrne; Motasem Kalaji; Amelia Greiner Safi; Norman Porticella; Alan D Mathios; Rosemary J Avery; Michael C Dorf; Jeff Niederdeppe Journal: Nicotine Tob Res Date: 2021-01-22 Impact factor: 4.244
Authors: Sabrina L Smiley; Kacie C A Blackman; Ricky N Bluthenthal; Yaneth L Rodriguez; Rosa Barahona; Steve Sussman; Mary Ann Pentz; Jonathan M Samet; Lourdes Baezconde-Garbanati Journal: Tob Regul Sci Date: 2018-07
Authors: Amira Osman; Sarah D Kowitt; Paschal Sheeran; Kristen L Jarman; Leah M Ranney; Adam O Goldstein Journal: Int J Environ Res Public Health Date: 2018-04-14 Impact factor: 3.390